Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Immunology, Microenvironment, and Metastasis Program, Wistar Institute, Philadelphia, PA, USA.
Nat Cancer. 2020 Jun;1(6):603-619. doi: 10.1038/s43018-020-0064-0. Epub 2020 May 25.
Primary tumor-derived factors (TDFs) act upon normal cells to generate a pre-metastatic niche, which promotes colonization of target organs by disseminated malignant cells. Here we report that TDFs-induced activation of the p38α kinase in lung fibroblasts plays a critical role in the formation of a pre-metastatic niche in the lungs and subsequent pulmonary metastases. Activation of p38α led to inactivation of type I interferon signaling and stimulation of expression of fibroblast activation protein (FAP). FAP played a key role in remodeling of the extracellular matrix as well as inducing the expression of chemokines that enable lung infiltration by neutrophils. Increased activity of p38 in normal cells was associated with metastatic disease and poor prognosis in human melanoma patients whereas inactivation of p38 suppressed lung metastases. We discuss the p38α-driven mechanisms stimulating the metastatic processes and potential use of p38 inhibitors in adjuvant therapy of metastatic cancers.
原发性肿瘤衍生因子 (TDFs) 作用于正常细胞以产生预先转移的生态位,从而促进播散的恶性细胞在靶器官的定植。在这里,我们报告 TDFs 诱导的肺成纤维细胞中 p38α 激酶的激活在肺部预先转移生态位的形成以及随后的肺转移中起着关键作用。p38α 的激活导致 I 型干扰素信号的失活和成纤维细胞激活蛋白 (FAP) 的表达刺激。FAP 在重塑细胞外基质以及诱导使中性粒细胞浸润肺部的趋化因子表达方面发挥了关键作用。正常细胞中 p38 的活性增加与黑色素瘤患者的转移性疾病和预后不良相关,而 p38 的失活抑制了肺转移。我们讨论了刺激转移过程的 p38α 驱动机制以及 p38 抑制剂在转移性癌症辅助治疗中的潜在用途。